Antibody Detection (ELISA) of Serious Fungal Infections
Antibody ELISAs detect host immune responses by measuring pathogen-specific immunoglobulins in serum. Fungal antigens are coated on the test surface, and patient antibodies bind if present. A secondary enzyme-linked reagent generates a signal, allowing assessment of prior exposure or active immune response to fungal pathogens.
Immunodiffusion (Precipitin Test) of Serious Fungal Infections
Immunodiffusion is a gel-based method in which fungal antigens and patient antibodies diffuse toward each other, forming visible precipitin lines when they meet at zones of equivalence. While less sensitive than ELISA, this technique provides confirmatory evidence of antibody specificity and remains a valuable tool in fungal serology.
American College of Chest Physicians (CHEST)
October 19-22, 2025 American College of Chest Physicians Chicago, IL MiraVista Diagnostics will be at this event. Booth # 1044 This event will bring you the most up-to-date education in clinical pulmonary, critical care, and sleep medicine with world-class speakers,…
READ MORE →
Infectious Disease Society of America (IDWeek)
October 19-22, 2025 Infectious Disease Society of America Atlanta, GA MiraVista Diagnostics will be at this event. Booth # 629 Surround yourself with the ID experts who are advancing the field of Infectious Disease. Choose scientific programming that’s tailored to…
READ MORE →
MiraVista Institutional Biosafety Committee (IBC) Announcement
In compliance with NIAID/NIH guidelines, research at MiraVista Diagnostics utilizing synthetic or recombinant DNA is annually reviewed by the MiraVista Institutional Biosafety Committee (IBC). The IBC is made up of internal and external subject matter experts to ensure that MiraVista…
READ MORE →
American College of Chest Physicians Boston, MA October 6-9, 2024
MIRAVISTA DIAGNOSTICS WILL BE AT THIS EVENT This event will bring you the most up-to-date education in clinical pulmonary, critical care,…
READ MORE →
ID WEEK Los Angeles, CA October 16-20, 2024
MIRAVISTA DIAGNOSTICS WILL BE AT THIS EVENT Surround yourself with the ID experts who are advancing the field of ID. Choose scientific programming that’s…
READ MORE →
MiraVista Institutional Biosafety Committee (IBC) Announcement
In compliance with NIAID/NIH guidelines research at MiraVista Diagnostics utilizing synthetic or recombinant DNA is annually reviewed by the MiraVista Institutional Biosafety Committee (IBC). The IBC is made up of internal and external subject matter experts to ensure that MiraVista…
READ MORE →
